Gタンパク質結合受容体の選択的光交互性アロステリックアゴニスト
Prashant Donthamsetti1, David B Konrad2, Belinda Hetzler3
1Department of Molecular and Cell Biology, University of California, Berkeley, California 94720, United States.
Journal of the American Chemical Society
|June 11, 2021
まとめ
研究者は新しい光スイッチ可能なアロステリックアゴニストであるaBINAを開発しました. この精密薬は光を用いてGタンパク質結合受容体2 (mGluR2) を選択的に活性化し,新たな治療的可能性を秘めています.
科学分野:
- 薬理学について
- 生物化学
- 分子生物学
背景:
- Gタンパク質結合受容体 (GPCR) は重要な薬物の標的ですが,それらの類似性と複雑な活性化ダイナミクスは課題となっています.
- 光薬学では 光で活性化された分子を使って 薬の作用を制御し 時間的・空間的な精度を提供します
- 現存する光薬学的手段には,光アゴニスト/反アゴニスト (非選択的) と光アロステリック調節器 (間接的制御) が含まれる.
研究 の 目的:
- GPCR活動の選択的かつ直接的な制御のために,光スイッチ可能なアロステリックアゴニストを設計する.
- GPCRおよび関連するシグナルタンパク質のための新種の精密薬を開発する.
主な方法:
- 光同化可能なアゾベンジンをGPCRリガンドに組み込み,光交換活性を生成する.
- 強化された選択性のために保存されていないサイトをターゲットにしたアロステリックモジュールターの設計.
- メタボトロピックグルタミン酸受容体2 (mGluR2) の光スイッチ可能なアロステリックアゴニストであるaBINAの開発と試験.
主要な成果:
- フォトスイッチ可能なアロステリックアゴニストであるaBINAの成功設計と合成.
- aBINAがGi/o結合メタボトロピックグルタミン酸受容体2 (mGluR2) を選択的に活性化することを示す.
- aBINAは,内生リガンドから独立して,光刺激で直接の受容体活性化をもたらします.
結論:
- aBINAは,GPCRのための新しい精密薬のクラスを表しています.
- このアプローチは,GPCRシグナリングの選択的で直接的な光ベースの制御を可能にします.
- 開発された技術は,GPCRやその他のシグナル伝達タンパク質を含む疾患の治療に有望である.
関連する概念動画
Activation and Inactivation of G Proteins
8.2K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.2K
Transducer Mechanism: G Protein–Coupled Receptors
3.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.1K
G-protein Coupled Receptors
126.7K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
126.7K
G Protein-coupled Receptors
14.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
14.5K
GPCR Desensitization
7.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.0K
The Two-State Receptor Model
2.7K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.7K


